SHIPPEO Expands in North America
9.2.2022 13:00:00 CET | Business Wire | Press Release
Shippeo, a global leader in real-time transportation visibility, announces today it’s expanding its North American operations and U.S. executive team, as well as enhancing its customer-centric, multi-modal visibility platform. The systemwide enhancements will support global customers and the company’s growing North American customer base.
During this time of supply chain disruption, when visibility data is a lifeline enabling companies to proactively manage freight flows, Shippeo will accelerate the number of secure, direct integrations with U.S.-based trucking companies, logistics providers and ocean carriers, and have access to data from their terminal and port operator trading partners. This will build out Shippeo’s comprehensive, global, neutral partner network to augment the flow of visibility data to customers.
Shippeo’s presence in North America has uncovered an underserved aspect of the market’s visibility offerings, the customer-centric supply chain. By putting customers and their ecosystem of suppliers first, Shippeo has achieved a dominant leadership position in Europe and the Middle East with over 130 customers, including global brands such as, Coca-Cola, Schneider Electric, Sappi, Kuehne + Nagel, ThyssenKrupp and Saint-Gobain. In addition, 97% of Shippeo’s customers on Gartner Peer Insights would recommend the Shippeo Visibility Platform.*
Shippeo’s aim is to provide customers with the critical visibility data needed to increase operational agility and efficiency, strengthen their company’s supply chain execution and deliver a better experience for their customers.
Joining Shippeo’s executive team are industry heavyweights, Christopher Mazza and Brian Shultz, who will head-up Shippeo’s U.S.-based growth initiative.
Christopher P. Mazza, Shippeo Senior Vice President of International Growth, will lead Shippeo’s expansion in North America and new markets. Chris has extensive knowledge and experience with freight and logistics technology solutions having held senior leadership roles with ClearMetal (acquired by Project44), XVELA (Navis), and International Assets Systems (acquired by Blume Global). In addition, Chris has served in operational and executive management positions with major ocean carriers including, Maersk, DSR-Senator and Hanjin.
Brian Shultz, Vice President Sales & Marketing, Americas, has been working in the international supply chain technology space for more than 20 years. He’s created and managed large logistics networks comprising all modes of transportation for logistics service providers, beneficial cargo owner (BCO) shippers (across multiple verticals), 3PLs and 4PLs. Brian has held senior leadership roles within ABB, International Assets Systems (acquired by Blume Global) and Navis (acquired by Accel-KKR), in addition to years of international supply chain consulting.
“There is no better time than now to accelerate Shippeo’s position within the North American market. Visibility data analytics is vital to helping companies proactively manage supply chain issues, especially now, as ongoing market and infrastructure challenges continue to disrupt transportation flows and reliable logistics processes. We’re excited to deliver enhanced, innovative Shippeo visibility solutions to support and strengthen our global customers and North American companies,” said Lucien Besse, COO at Shippeo.
* Gartner Disclaimer: As of February 2nd 2022 based on 92 reviews in the Real-Time Transportation Visibility Platforms market. Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220208005844/en/
Contact information
Press contact:
Carol Lerner, CKL Communications, 201-602-7572, ckl.communications@gmail.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press Release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press Release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press Release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
